Prostacyclin analog with alpha-1 adrenergic agonist

This page covers all Prostacyclin analog with alpha-1 adrenergic agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostacyclin receptor (IP receptor); alpha-1 adrenergic receptor.

Targets

Prostacyclin receptor (IP receptor); alpha-1 adrenergic receptor

Marketed (1)

• Inhaled Epoprostenol and phenylephrine · University Health Network, Toronto · Cardiovascular
  Inhaled epoprostenol acts as a pulmonary vasodilator via prostacyclin receptor activation, while phenylephrine provides systemic vasoconstriction to maintain blood pressure.

Patent intelligence

• prostacyclin analog with alpha 1 adrenergic agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates